81 related articles for article (PubMed ID: 23838215)
1. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition.
See I; Iwamoto M; Allen-Bridson K; Horan T; Magill SS; Thompson ND
Infect Control Hosp Epidemiol; 2013 Aug; 34(8):769-76. PubMed ID: 23838215
[TBL] [Abstract][Full Text] [Related]
2. The applicability of the central line-associated bloodstream infection (CLABSI) criteria for the evaluation of bacteremia episodes in pediatric oncology patients.
van den Bosch CH; Frakking FNJ; Loeffen YGT; van Tinteren H; van der Steeg AFW; Wijnen MHWA; van de Wetering MD; van der Bruggen JT
Eur J Haematol; 2024 May; 112(5):832-839. PubMed ID: 38294085
[TBL] [Abstract][Full Text] [Related]
3. Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals.
Yu KC; Jung M; Ai C
Infect Control Hosp Epidemiol; 2023 Dec; 44(12):1920-1926. PubMed ID: 37424226
[TBL] [Abstract][Full Text] [Related]
4. Association between parenteral nutrition-containing intravenous lipid emulsion and bloodstream infections in patients with single-lumen central venous access: A secondary analysis of a randomized trial.
Gavin NC; Larsen E; Runnegar N; Mihala G; Keogh S; McMillan D; Ray-Barruel G; Rickard CM
JPEN J Parenter Enteral Nutr; 2023 Aug; 47(6):783-795. PubMed ID: 37288612
[TBL] [Abstract][Full Text] [Related]
5. Implementing and validating a home-infusion central-line-associated bloodstream infection surveillance definition.
Keller SC; Hannum SM; Weems K; Oladapo-Shittu O; Salinas AB; Marsteller JA; Gurses AP; Klein EY; Shpitser I; Crnich CJ; Bhanot N; Rock C; Cosgrove SE;
Infect Control Hosp Epidemiol; 2023 Nov; 44(11):1748-1759. PubMed ID: 37078467
[TBL] [Abstract][Full Text] [Related]
6. Etiology and utility of hospital-onset bacteremia as a safety metric for targeted harm reduction.
Stack MA; Dbeibo L; Fadel W; Kelley K; Sadowski J; Beeler C
Am J Infect Control; 2024 Feb; 52(2):195-199. PubMed ID: 37295676
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic and microbiologic evaluation of catheter-line bloodstream infection in a pediatric hematopoietic stem cell transplant center.
Aksoy BA; Kara M; Sütçü M; Özbek A; Ersoy GZ; Öner ÖB; Aydoğdu S; Gül D; Bozkurt C; Fışgın T
Am J Infect Control; 2024 Jan; 52(1):81-86. PubMed ID: 37591312
[TBL] [Abstract][Full Text] [Related]
8. Hospital-acquired bloodstream infections in patients with cancer: current knowledge and future directions.
MacPhail A; Dendle C; Slavin M; McQuilten Z
J Hosp Infect; 2024 Jun; 148():39-50. PubMed ID: 38490489
[TBL] [Abstract][Full Text] [Related]
9. Central Line-Associated Bloodstream Infection Misclassifications-Rethinking the Centers for Disease Control and Prevention's Central Line-Associated Bloodstream Infection Definition and Its Implications.
Sopirala MM; Estelle CD; Houston L
Crit Care Med; 2024 Mar; 52(3):357-361. PubMed ID: 38180116
[TBL] [Abstract][Full Text] [Related]
10. Pilot validation of central line-associated bloodstream infection data in a voluntary surveillance system in Taiwan between October and December 2021.
Wu HH; Chang SL; Su CH; Tseng SH; Chien LJ
Infect Prev Pract; 2024 Mar; 6(1):100326. PubMed ID: 38077243
[TBL] [Abstract][Full Text] [Related]
11. Controlling the chaos: Information management in home-infusion central-line-associated bloodstream infection (CLABSI) surveillance.
Hannum SM; Oladapo-Shittu O; Salinas AB; Weems K; Marsteller J; Gurses AP; Shpitser I; Klein E; Cosgrove SE; Keller SC
Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e69. PubMed ID: 37113198
[TBL] [Abstract][Full Text] [Related]
12. Prevention of Vascular Access Device-Associated Hospital Onset Bacteremia and Fungemia: A Review of Emerging Perspectives and Synthesis of Technical Aspects.
Garcia R; Septimus EJ; LeDonne J; Sturm LK; Moureau N; DeVries M; DeBaun B
Clin Infect Dis; 2024 May; ():. PubMed ID: 38709254
[TBL] [Abstract][Full Text] [Related]
13. Hospital-onset bacteremia and fungemia: examining healthcare-associated infections prevention through a wider lens.
Schrank GM; Snyder GM; Leekha S
Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e198. PubMed ID: 38028924
[TBL] [Abstract][Full Text] [Related]
14. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology, and stem cell transplant patients.
Metzger KE; Rucker Y; Callaghan M; Churchill M; Jovanovic BD; Zembower TR; Bolon MK
Infect Control Hosp Epidemiol; 2015 Feb; 36(2):119-24. PubMed ID: 25632993
[TBL] [Abstract][Full Text] [Related]
15. Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013.
Epstein L; See I; Edwards JR; Magill SS; Thompson ND
Infect Control Hosp Epidemiol; 2016 Jan; 37(1):2-7. PubMed ID: 26456954
[TBL] [Abstract][Full Text] [Related]
16. Mucosal barrier injury laboratory--confirmed bloodstream infection or contaminant?
Semel JD
Infect Control Hosp Epidemiol; 2013 Dec; 34(12):1330-1. PubMed ID: 24225625
[No Abstract] [Full Text] [Related]
17. The Centers for Disease Control and Prevention definition of mucosal barrier injury-associated bloodstream infection improves accurate detection of preventable bacteremia rates at a pediatric cancer center in a low- to middle-income country.
Torres D; González ML; Loera A; Aguilera M; Relyea G; Aristizabal P; Caniza MA
Am J Infect Control; 2016 Apr; 44(4):432-7. PubMed ID: 26775931
[TBL] [Abstract][Full Text] [Related]
18. Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies.
Tancrède CH; Andremont AO
J Infect Dis; 1985 Jul; 152(1):99-103. PubMed ID: 3925032
[TBL] [Abstract][Full Text] [Related]
19. Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan.
Kato Y; Hagihara M; Kurumiya A; Takahashi T; Sakata M; Shibata Y; Kato H; Shiota A; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jan; 24(1):31-35. PubMed ID: 29066217
[TBL] [Abstract][Full Text] [Related]
20. Improving the central line-associated bloodstream infection surveillance definition: a work in progress.
Steinberg JP; Coffin SE
Infect Control Hosp Epidemiol; 2013 Aug; 34(8):777-9. PubMed ID: 23838216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
